Precigen (PGEN) Total Current Liabilities (2012 - 2026)
Precigen (PGEN) posted quarterly Total Current Liabilities of $21.1 million for Q1 2026, down 12.02% year-over-year from $24.0 million in Q1 2025, and down 43.43% quarter-over-quarter from $37.3 million in Q4 2025.
Precigen (PGEN) Total Current Liabilities (2012 - 2026) Analysis & Trends
Precigen (PGEN) has reported Total Current Liabilities for 15 consecutive years, with $21.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Current Liabilities fell 12.02% year-over-year to $21.1 million; the TTM figure through Mar 2026 stood at $21.1 million (down 12.02% YoY), while the FY2025 annual figure was $37.3 million, up 73.37% from the prior year.
- Total Current Liabilities fell to $21.1 million in Q1 2026 per PGEN's latest filing, from $37.3 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $104.9 million in Q3 2022 and bottomed at $21.1 million in Q1 2026.
- Historically, Total Current Liabilities has averaged $35.6 million across 5 years, with a median of $28.8 million in 2024.
- Annual changes were most pronounced in 2022 — Total Current Liabilities jumped 261.74% — and 2023, when it tumbled 70.77%.
- Precigen's Total Current Liabilities stood at $78.6 million in 2022, then sank by 70.77% to $23.0 million in 2023, then decreased by 6.38% to $21.5 million in 2024, then surged by 73.37% to $37.3 million in 2025, then tumbled by 43.43% to $21.1 million in 2026.
- Business Quant data shows PGEN's Total Current Liabilities at $21.1 million in Q1 2026, $37.3 million in Q4 2025, and $32.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.58 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 354.06 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 2.12 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4.22 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 630.93 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.51 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 438.74 Mn |
| 10 | Precigen | 2.18 Bn | 2.18 Bn | 52.17 Mn | 29.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 29.35 Mn |
| Mar 31, 2026 | 21.10 Mn |
| Dec 31, 2025 | 37.31 Mn |
| Sep 30, 2025 | 32.07 Mn |
| Jun 30, 2025 | 23.19 Mn |
| Mar 31, 2025 | 23.99 Mn |
| Dec 31, 2024 | 21.52 Mn |
| Sep 30, 2024 | 21.22 Mn |
| Jun 30, 2024 | 23.02 Mn |
| Mar 31, 2024 | 28.77 Mn |
| Dec 31, 2023 | 22.99 Mn |
| Sep 30, 2023 | 32.88 Mn |
| Jun 30, 2023 | 30.77 Mn |
| Mar 31, 2023 | 46.73 Mn |
| Dec 31, 2022 | 78.65 Mn |
| Sep 30, 2022 | 104.86 Mn |
| Jun 30, 2022 | 29.90 Mn |
| Mar 31, 2022 | 25.60 Mn |
| Dec 31, 2021 | 34.65 Mn |
| Sep 30, 2021 | 28.99 Mn |